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Summary
Objective: Articular cartilage has only limited capacities for repair and it is not known what is the exact mechanism
of matrix restoration. It was investigated whether the reparative process in murine articular cartilage after moderate
proteoglycan depletion is accompanied by a change in the chondrocyte phenotype either to hypertrophy or to a less
differentiated phenotype as assayed by the expression of specific collagen subtypes.
Design: Moderate proteoglycan depletion was induced by injection of papain whereafter the expression of collagen
type I mRNA, collagen IIA and IIB mRNA and type X collagen mRNA in patellar cartilage, as markers for chondrocyte
phenotype, was investigated by RT-PCR during normal cartilage physiology and matrix restoration. In addition, in-situ
expression of collagen subtypes was assayed by immunolocalisation.
Results: In normal articular cartilage collagen I, collagen IIB and collagen type X transcripts were easily detected.
Surprisingly, collagen type I sense as well as antisense mRNA was detected and in addition to IIB transcripts collagen
IIA transcripts were detected in a number of samples. During cartilage matrix restoration no change in the expression
of collagen I, collagen IIA or IIB or collagen type X mRNA transcripts could be detected. Immunolocalization
demonstrated the presence of type I (pericellular) and type II collagen in the extracellular matrix. The pericellular
matrix of hypertrophic chondrocytes showed collagen type X staining in the calcified cartilage in normal and
papain-injected knee joints. Increased staining for collagen type X was found in the upper cartilage layer in the
interterritorial matrix from day 7 after papain injection.
Conclusion: The absence of changes in collagen mRNA expression indicates that alteration of chondrocyte
phenotype does not occur during the successful repair process after moderate proteoglycan depletion. Collagen type
X appears to be deposited in the upper cartilage layer during this process.
Keywords: Chondrocytes, Repair, Collagen I, Collagen II, Collagen X.
Introduction
Articular cartilage, covering the end of long
bones, makes a nearly frictionless movement of the
articulating surfaces possible. All the structural
constituents of articular cartilage such as colla-
gens and proteoglycans, necessary to perform this
specific function, are during adult life synthesized
by differentiated articular chondrocytes. Devi-
ation from this articular chondrocyte-specific
phenotype will lead to the synthesis of molecules
normally not expressed in articular cartilage and
will result in functional impairment of the affected
cartilage. The differentiation stage of the chondro-
cyte can be monitored by analysis of the expression
of different collagen subtypes amongst other
collagen types I, II and X. Collagen type I, a
heterotrimer consisting of two a1(I) and one a2(I)
subunits, is the major collagen produced by
prechondrogenic mesenchymal cells. As these cells
differentiate into cartilage-producing cells these
cells terminate collagen type I synthesis and
initiate the synthesis of cartilage-specific collagens
such as type II, IX and XI [1]. However, during
chondrocyte culture and under pathological con-
ditions such as osteoarthritis collagen type I
appears to be re-expressed [2–5].
Collagen type II is the predominant component
of articular cartilage where it provides structural
integrity to this tissue. The type II collagen is a
triple helical molecule consisting of three identical
a1(II) chains. Collagen type II is found in two
Received 26 November 1997; accepted 1 July 1998.
Correspondence to: Peter M. van der Kraan, Department
of Rheumatology, University Hospital Nijmegen, Geert
Grooteplein 8, 6525 GA Nijmegen, The Netherlands.
Tel: 31-24-3616568; Fax: 31-24-3540403; E-mail:
P.vanderKraan@reuma.azn.nl
( Present address: Apotex Research Inc. Toronto, Canada.
417
van der Kraan et al.: Murine cartilage collagen mRNA expression418
isoforms which are generated by alternative
splicing of pre-mRNA. These two splice forms are
alternatively expressed by chondrocytic cells
during different stages of their differentiation. One
procollagen form, called IIA, contains exon 2 and
is expressed mainly by chondroprogenitor cells.
The isoform called IIB, lacking exon 2, is specific
for differentiated chondrocytes [6–9].
Collagen type X, a homotrimer of a(X) chains, is
ordinarily not expressed in non-calcified articular
cartilage but specific for hypertrophic chondro-
cytes. Its typical location is therefore the growth
plate and calcified articular cartilage [10–12].
However, during cell culture and pathological
conditions like human and experimental osteoar-
thritis strong expression of collagen type X is
found in articular chondrocytes derived from
non-calcified cartilage [13–17].
Articular cartilage has only limited capacities
for repair but at least a certain amount of damage
can be repaired by the chondrocytes. Until now it
is not known what is the exact mechanism of
matrix repair and if there is a change in phenotype
of the articular chondrocyte during restoration of
the cartilage matrix. To acquire insight whether
the reparative process in murine articular carti-
lage is accompanied by a change in the chondro-
cyte phenotype either to hypertrophy or to a less
differentiated phenotype, the expression of colla-
gen type I mRNA, collagen IIA and IIB mRNA and
type X collagen mRNA in patellar cartilage was
investigated by RT-PCR during normal cartilage
physiology and during matrix restoration after
mild proteoglycan depletion. Moreover, in-situ
expression of collagen type I, II and X was studied
by immunohistochemistry.
Material and methods
Animals
Male C57B1/6 mice at 10–12 weeks (young adult)
were used. The animals were kept in cages with a
wood chip bedding in air-conditioned rooms at a
constant temperature. They were fed a standard
laboratory diet and had access to water ad libitum.
In experiments detecting collagen type IIA and IIB
mRNA, RNA isolated from mouse limbs of
12-day-old C57B1/6 embryos was used as a positive
control. In all experiments the groups of mice
consisted of 6 animals or more.
Isolation of RNA from murine patellar
cartilage and embryo limbs
Patellar cartilage was obtained and RNA was
isolated as described earlier [18, 19]. Patellae were
dissected from murine knee joints and immediately
decalcified at 4° C in 3.5% EDTA (Sigma, St Louis,
MO, U.S.A.). Following decalcification the com-
plete articular cartilage layer was stripped from
the underlying bone. In some experiments the
stripped patellar cartilage was divided in a central
and a peripheral part by use of a small punch
(0.2 mm2) as described before [20]. The isolated
cartilage was immediately put in TRIzol reagent
(Life Technologies Inc) for extraction of total
RNA. In earlier studies it was demonstrated that
this procedure did not affect the RNA isolation or
RT-PCR performance negatively [18]. In all
RT-PCR experiments cartilage of 5 patellae was
pooled. In addition, total RNA was isolated from
the limbs of 12-day-old C57B1 embryos by direct
extraction with TRIzol reagent.
Reverse transcriptase PCR
The RNA isolated from the cartilage and murine
embryonic limbs was treated with DNAse I (Life
Technologies Inc) to remove possible contami-
nation of the samples with genomic DNA. The
reverse transcription (RT) reaction was performed
at 39° C with moloney-murine leukemia virus
(M-MLV) reverse transcriptase (Life Technologies
Inc) using oligo(dT)15 primers (Eurogentic, Liege,
Belgium). When specific upper or lower primers
were used in the RT reaction for the detection of
sense and antisense messenger RNA separately,
RT reactions were carried out with superscript II
RNAse H - (Life Technologies Inc) at 50° C.
Amplification of cDNA was accomplished by using
Taq DNA polymerase (Life Technologies Inc) up to
a maximal cycle number of 40. To estimate the
relative mRNA levels, samples of 5 ml were taken
at increasing cycle numbers with an interval of 2
cycles. The PCR products were electrophorised in
1.5% agarose gels containing ethidium bromide.
The cycle number at which the product was first
detected was taken as a measure for the amount of
specific mRNA. In the case of estimation of
collagen mRNA levels, glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) mRNA levels were used
as an internal control. Due to the limited amount
of tissue and consequently RNA quantities,
measurement of the amount of total RNA was
impossible. All RT-PCR reactions were performed
in duplicate. The primers used in the amplification
reactions and specific sense and antisense mRNA
reverse transcription reactions were the following.
Collagen type I (a1(I) total mRNA was detected
using oligodT in combination with 5'–GGGCCACT-
GCCCTCCTGACG–3' and 5'–AGCACCCGCCCTC-
CCGTCTT as upper and lower primer (mRNA
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position 230–249 and 387–406, respectively. For the
detection of collagen type I sense mRNA the RT
reaction was performed with the lower primer
while detection of antisense mRNA was carried out
with the upper primer for cDNA synthesis.
The primers used to detect murine collagen II
discriminate between collagen IIA and collagen
IIB. The upper primer (5'–GCCTCGCGGTGAGC-
CATGATC–3') is situated on exon 1 (gene position
393–413) while the lower primer is positioned on
exon 4 (5'–GAGGGCCAGGAGGTCCTCTGG–3',
gene position 8815–8835). Since collagen IIB lacks
exon 2 the product size IIB will be 177 bp while the
product size of IIA (including exon 2) is 384 bp,
therefore IIA and IIB collagen mRNA can be
detected in a single reaction. Primers detecting
murine collagen type X had the following
sequences 5'–ATACCCTTTCTGCTGCTAAT-
GTTCTTGACC–3' (upper, gene position 1663–1692)
and 5'–TGATATTCCTGGTGGTCCTGGCAAC–3'
(lower, gene position 5349–5373) resulting in a
product of 387 bp. The specific upper and lower
primers were used during cDNA synthesis for the
detection of sense and antisense mRNA. To detect
GAPDH the primers 5'–AACTCCCTCAAGATT-
GTCAGCA–3' and 5'–TCCACCACCCTGTTGGCT-
GTA–3' were used (product 553 bp). Primer
sequences were selected with computer programs
Primer (Whitehead Institute, Cambridge, MA) and
oligo 4.0 (National Biosciences, Plymouth, MN)
and sequence data from international data banks.
Immunolocalisation of collagen I, II and X
Collagen type I was stained with a commercially
available polyclonal rabbit antibody (Biogenesis,
Poole, UK). To stain collagen type II the
monoclonal antibody (IgG2a) CIICI developed by
Holmdahl and Rubin was used [21]. This antibody
was obtained from the Developmental Studies
Hybridoma Bank maintained by The University of
Iowa, Department of Biological Sciences, Iowa
City, IA 52242, under contract N01-HD-7-3263 from
the NICHD. Collagen type X was stained with a
polyclonal rabbit antibody which was developed by
one of the co-authors (TM). This antibody was
raised against a human NC1 synthetic peptide. The
human and mouse sequences of this peptide have
only a single amino acid difference. This antibody
did not show cross-reactivity against collagen type
I, II, IX and XI.
Patellae were dissected in toto and were rapidly
frozen in liquid nitrogen and stored at - 70° C.
Undecalcified cryosections were cut on a cryostat
and mounted on glass microscopic slides. Sections
were dried for one hour, fixed for 5 minutes in
freshly prepared 4% formaldehyde and washed
extensively in 0.1 M phosphate buffered saline
(pH 7.4, PBS) for 15 minutes. To enhance the
permeability of the extracellular matrix gly-
cosaminoglycans were removed by incubating the
sections with 1% hyaluronidase (type I-s, Sigma)
for 30 minutes at 37° C. Endogenous peroxidase was
blocked by freshly prepared 1% (vol/vol) H2O2 in
absolute ethanol for 30 mins. Non-specific staining
was blocked by incubation of the sections with
10% normal horse serum in PBS with 1% bovine
serum albumin (Sigma). Sections were incubated
with the corresponding biotinylated second anti-
body whereafter staining was performed with a
biotin–streptavidin detection system (Vectra elite
kit, Vectra, Burlington, CA, U.S.A.).
Induction of moderate proteoglycan
depletion
Proteoglycan depletion was induced as de-
scribed by van der Kraan et al. [19, 22]. In short, the
right knee joint of mice was injected once with 6 ml
of a 0.5% papain solution (type IV, 15 units/mg,
Sigma) which was activated by supplementation
with 0.03 M L-cysteine-HCl (Sigma). Control knee
joints were injected with physiological saline. The
papain injection has been shown to result in a
moderate depletion of proteoglycans which is
standardly restored to normal after approximately
10–14 days [19].
Depletion and restoration of articular cartilage
proteoglycan content was examined by safranin O
staining of histologic sections [19]. At 1, 2, 3, 7 and
21 days after papain injection patella were isolated
and collagen mRNA levels were estimated. Ex-
pression of mRNA in the papain-injected knees
was compared with the levels in saline-injected
knees from the same animals. On day 3, 7 and 21
patellae were harvested for immunolocalisation of
collagen type I, II and X.
Results
Proteoglycan depletion and replenishment
after papain injection
Figure 1 shows safranin O/fast green stained
sections of murine knee joints after injection
of 0.5% papain. Safranin O staining in the
cartilage matrix is directly related to the proteo-
glycan content of the cartilage. Depletion of
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proteoglycans is clearly visible on day 3 after
injection of papain in the non-calcified part of the
patellar and tibial cartilage [Fig. 1(b)]. The
proteoglycan content of the deeper, calcified layer
is not affected by the papain injection. The
proteoglycan depletion of the patellar cartilage on
day 3 is restored to normal on day 10 after papain
injection [Fig. 1(c)]. At all time points examined,
both in papain-injected and contralateral knees
collagen I, collagen IIB and expression of collagen
type X mRNA transcripts were detected.
Expression of collagen mRNA
Collagen type I
It was investigated whether collagen type I
mRNA is expressed in normal non-damaged murine
articular cartilage. In patellar cartilage collagen
type I mRNA was detected by use of RT-PCR
(Fig. 2). Since collagen type I is a protein not
normally expressed in articular cartilage we
examined if the expression of collagen type I
mRNA was confined to the peripheral part of the
Fig. 1a.
Fig. 1b.
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Fig. 1c.
Fig. 1. Photograph of murine knee joints after injection of 0.5% papain. (a) Control. Depletion of proteoglycans is
clearly visible on day 3 after injection of papain in the non-calcified part of the patellar and tibial cartilage (b). The
proteoglycan content of the deeper calcified layer is not affected by the papain injection. The proteoglycan depletion
of the patellar cartilage on day 3 is restored to normal on day 10 (c). P, patella; F, femur. Safranin O/fast green. · 100.
patellar cartilage adjacent to the periosteum.
However, both the central and the peripheral part
of the patellar cartilage expressed collagen type I
mRNA. To investigate whether the expression of
collagen type I mRNA we observed was the
sense mRNA we performed the RT reaction with
primers specific for sense or anti-sense mRNA,
respectively. As can be seen in Fig. 2, not only
sense but also antisense mRNA was easily detected
in central as well as peripheral patellar cartilage.
Sense mRNA was detected in the central part of
the patellae at cycle 28 while antisense mRNA was
detected at cycle 31.
Collagen type II
It has been shown that differentiated articular
chondrocytes express collagen type II mRNA
transcripts which lack exon 2 (collagen IIB).
Surprisingly, normal patellar cartilage of young
adult mice showed collagen IIA transcripts
(384 bp) in a number of specimens although IIB
expression was always the far most dominant
transcript (Fig. 3). No difference was found
between the central or peripheral part of the
patellar cartilage with regard to the relative
expression of type IIA or IIB mRNA (not shown).
Murine embryonic limb cartilage (day 12), used as
a control, appeared to express mainly collagen
type IIA.
Collagen type X
The mRNA expression of the hypertrophic
chondrocyte-specific collagen type X was investi-
gated in patellar cartilage. Expression of collagen
type X was plainly detectable using oligodT or
sense specific RT primers (Fig. 4). Since no growth
plate cartilage is present in the patellae this
Fig. 2. RT-PCR of collagen type I total (oligodT), sense
and anti-sense mRNA in central and peripheral patellar
cartilage. Samples of 5 ml were taken at alternating cycle
numbers (interval of 2 cycles), starting at cycle 28 and
ending at cycle 36, and the PCR products were
electrophorised in 1.5% agarose gels containing ethid-
ium bromide. In all RT-PCR experiments cartilage of five
patellae was pooled.
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Fig. 3. RT-PCR of procollagen type II (a1(II)) mRNA by
use of primers located on exon 1 and exon 4. RNA was
derived from embryonic limbs or patellar cartilage from
young adult mice. After 35 cycles a sample was taken
and electrophorised in a 1.5% agarose gel. Expression of
collagen IIA mRNA will result in a band of 384 bp while
expression of IIB will result in a 177 bp band. In all
RT-PCR experiments cartilage of five patellae was
pooled.
Fig. 5. Relative expression of collagen type I mRNA,
collagen IIB mRNA and collagen type X mRNA in
papain-injected knee joints. Samples of 5 ml were taken
at increasing cycle numbers and the PCR products were
electrophorised in 1.5% agarose gels containing ethid-
ium bromide. The cycle number at which the product
was first detected was used for generating the results in
this figure. The expression of GAPDH in the same
samples was used as an internal control. The expression
ratio between the papain-injected and contra-lateral
knee joints of the same animals is expressed (mean of
three experiments). In all RT-PCR experiments cartilage
of five patellae was pooled. w, collagen type I; Q,
collagen type IIB; W, collagen type X.
type I, collagen IIA and IIB and collagen type X
mRNA. No significant changes in the relative
expression of collagen I, collagen IIB or collagen
X could be detected during the course of matrix
proteoglycan depletion and matrix proteoglycan
replenishment as compared to the mRNA ex-
pression in the contralateral, saline-injected joints
(Fig. 5). Moreover, collagen IIA was occasionally
expressed in adult murine cartilage but no
alterations in the IIA to IIB ratio could be detected
after papain injection (data not shown).
collagen type X message is most likely derived from
the hypertrophic chondrocytes in the calcified
cartilage adjacent to the subchondral bone.
Collagen type X antisense mRNA appeared to be
expressed at very low levels, if at al, in this
cartilage.
Changes in collagen mRNA expression during
matrix restoration
Because in many tissues repair processes are
accompanied by changes in the differentiation
state of the cells involved we studied whether
chondrocytes participating in restoration of the
articular cartilage matrix undergo phenotypic
changes as measured by the expression of collagen
Fig. 6. Staining of patellar cartilage with a polyclonal
anti-collagen type I antibody. Staining can be clearly
seen in the subchondral bone, the cartilage surface and
in the pericellular matrix of the chondrocytes (magnifi-
cation · 80).
Fig. 4. RT-PCR of collagen type X total (oligodT), sense
and anti-sense mRNA in murine patellar cartilage.
Samples of 5 ml were taken at every 2 cycles (interval 2),
starting at 30 and ending at 36 cycles. The PCR products
were electrophorised in 1.5% agarose gels containing
ethidium bromide. In all RT-PCR experiments cartilage
of five patellae was pooled.
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Fig. 7. Staining of patellar cartilage with a monoclonal antibody against collagen type II. Strong staining was present
in the articular cartilage and cartilage remnants in the bone. No staining was found in the subchondral bone. The
pericellular matrix appeared to stain more intensely than the interterritorial matrix. Already on day 3 there was a
clear increase in collagen type II staining in the surface layer which normalized at later time points. (a) control, (b),
(c), (d), respectively day 3, 7 and 21 after papain injection, magnification · 80.
Immunolocalisation of collagen type I, II
and X
In patellar cartilage staining with anti-collagen
type I antibodies was found pericellular and at the
cartilage surface (Fig. 6). Staining was nearly
absent in the interterritorial matrix. No changes
were found after injection of papain. Bone showed
clear staining with this antibody.
Staining with the anti-collagen type II antibody
was confined to the articular cartilage and
cartilage remnants in the subchondral bone [Fig 7,
(a–d)]. In control sections, staining was seen
throughout the cartilage but appeared to be more
intense pericellular than interterritorial [Fig.
7(a)]. On day 3 after injection of papain staining of
the upper cartilage layer was more intense in the
injected than in the control section [Fig. 7(b)]. This
more intense staining in the surface zone gradually
disappeared on later time points [Fig. 7(c) and
7(d)]. Staining on day 21 after papain injection
was similar in the papain-injected and control
sections.
In control sections and in sections 3 days after
injection of papain collagen type X staining was
restricted to the hypertrophic chondrocytes in the
calcified cartilage layer (Fig. 8). However, on day
7 and day 21 after papain injection parts of the
surface layer stained positive with the anti-colla-
gen type X antibody [Fig. 8(c) and 8(d)]. Remark-
ably, this staining was more interterritorial than
pericellular suggesting that the surface zone
chondrocytes are not the source of the deposited
collagen type X. No staining was detected with the
above described antibodies when the first anti-
bodies were omitted.
Discussion
The expression of collagen type I mRNA,
collagen IIA and IIB mRNA and type X collagen
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mRNA was investigated by RT-PCR during normal
physiology of patellar cartilage and during matrix
restoration after mild proteoglycan depletion.
Both in papain-injected and contralateral knees
collagen I, collagen IIB and collagen type X
transcripts were detected. Surprisingly, collagen
type I sense as well as antisense mRNA was easily
detected and papain-injected as well as contralat-
eral knees showed collagen IIA transcripts in a
number of samples.
Collagen type I (a1(I)) mRNA was found in both
central and peripheral patellar cartilage. Since
expression of type I mRNA was not restricted to
the peripheral cartilage it is unlikely that the
expression of these transcripts can be attributed to
less differentiated chondrocytes at the periphery of
the patellar cartilage. Expression of collagen type
I mRNA [a1(I)] in adult articular cartilage of
various species has been reported in earlier studies
[23, 24]. Moreover, chondrocytes in chondro-os-
teophytes in the dog model of osteoarthritis
appeared to express collagen type I mRNA in
addition to IIB mRNA expression [25]. Remark-
ably, not only collagen type I sense but also
antisense mRNA was expressed by the murine
patellar chondrocytes. The expression of antisense
mRNA in articular chondrocytes might play a role
in the inhibition of translation of collagen type I
sense mRNA preventing in this way the synthesis
of collagen type I protein, as suggested by Farrell
and Lukens for embryonic chick chondrocytes [23].
Immunolocalization showed collagen type I
throughout the articular cartilage of the patellae
in the pericellular matrix. Also in other species the
presence of collagen type I protein has been shown
in articular cartilage [24]. However, this does not
necessarily indicate collagen type I synthesis since
the detected collagen type I can be deposited
during development. Transcripts for procollagen
IIA mRNA were detected in a number of specimens
Fig. 8. Staining of patellar cartilage with a polyclonal antibody against collagen type X. In control cartilage the
staining is confined to the pericellular matrix of the hypertrophic chondrocytes in the deep, calcified layer. On day
7 and day 21 after papain injection certain areas of the surface layer show clear staining with the anti-collagen type
X antibody. This staining appears to be more intense in the interterritorial matrix than in the peripheral matrix of
the chondrocytes. (a) control, (b), (c), (d), respectively day 3, 7 and 21 after papain injection, magnification · 80.
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but as expected, expression of collagen IIB was
always much higher than IIA. Expression of
procollagen IIA has been described in human
perichondrium [6]. However, collagen IIA ex-
pression appeared not to be restricted to the border
of the cartilage adjacent to the periosteum since
IIA could be easily detected also in the central
cartilage part in a number of cases. The presence
of collagen IIA might be normal for the relatively
young animals used (12 weeks, young adult), or
might be due to undetected joint pathology.
Collagen type X transcripts were clearly de-
tectable in murine articular cartilage. This can be
attributed to the presence of hypertrophic
chondrocytes in the deep, calcified layers of
patellar cartilage. Since our methodology makes it
impossible to separate the calcified and the
non-calcified layer we were unable to test this with
RT-PCR technology.
During joint pathology like osteoarthritis
changes in collagen mRNA synthesis of the
residing chondrocytes have been reported [2, 15–
17]. The change in collagen synthesis is considered
to reflect an altered chondrocyte phenotype
during the pathological process. The initiation of
collagen type I synthesis is considered to be an
indication of a less differentiated phenotype
involved in an attempted repair process while the
expression of collagen type X indicates a termi-
nally differentiated chondrocyte normally not
found in noncalcified articular cartilage. The
expression of hypertrophic chondrocytes in os-
teoarthritic cartilage is most probably related to
the calcifications often observed in osteoarthritic
cartilage [26, 27]. We have studied changes in
chondrocyte phenotype after reversible cartilage
damage, mild proteoglycan depletion. No changes
in the relative expression of collagen mRNA
could be detected (collagen type I sense and
antisense, collagen IIA and IIB and collagen X) in
papain-injected knees compared to control knee
joints. This indicates that phenotypic changes
of the chondrocytes after reversible cartilage
damage is not occurring. Immunolocalization
showed the presence of collagen type I, II and X in
the cartilage matrix of the patellae. In control
sections type I was seen mainly in the peripheral
matrix and at the cartilage surface while type II
was found throughout the matrix. Type X collagen
was confined to the pericellular matrix of the
chondrocytes in the deeper, calcified layer. After
injection of papain, no changes in the staining
with the anti-collagen type I antibody was
observed. However, type II staining clearly
increased in the surface zone on day 3 after papain
injection. This is most probably a reflection of a
better availability of the collagen type II epitopes
on this time point since staining was already less
intense on day 7 and day 21. On day 3 after papain
injection proteoglycan depletion of the non-cal-
cified cartilage layer is maximal whereafter the
proteoglycan content of the cartilage matrix is
restored.
Collagen type X staining increased in the surface
layer of the cartilage on day 7 and 21 after papain
injection. This is most likely not due to a better
availability of epitopes since on day 21 the
proteoglycan content of the articular cartilage is
similar to control cartilage. The increased staining
appears to reflect an increased deposition of
collagen type X in the surface zone. Since no
upregulation of collagen type X mRNA was
detected and the staining was most intense in the
interterritorial matrix of the surface layer the
chondrocytes in the upper cartilage layer are
unlikely to be the source of the deposited collagen
type X. Additionally, alkaline phosphatase stain-
ing was negative in the surface zone chondrocytes
after papain injection while being positive in the
hypertrophic chondrocytes in the calcified carti-
lage layer (data not shown). Rucklidge et al.
demonstrated the presence of collagen type X in
the surface zone of normal articular human, rat
and pig cartilage [28]. However, since we found
collagen type X surface staining in cartilage after
initial cartilage damage but not in control murine
cartilage the collagen type X surface staining
appears to be related to restoration of the cartilage
matrix.
In summary, we found that during normal
cartilage physiology in murine patellar cartilage
collagen type I sense and antisense mRNA,
procollagen IIB and IIA and collagen X could be
detected by RT-PCR. During matrix restoration
after papain-induced proteoglycan depletion no
change in collagen mRNA expression was detected
making phenotypic alterations of chondrocytes
during the successful repair process unlikely.
Moreover, during the restoration process an
increased deposition of collagen type X was
observed in the interterritorial matrix of the
cartilage surface zone.
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